Evaluation of effects of busulfan and DMA on SOS in pediatric stem cell recipients

E-ISSN： 1545-5017|61|2|306-311

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.61, Iss.2, 2014-02, pp. : 306-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infection surveillance in pediatric hematopoietic stem cell transplantation recipients

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 69-74

John Wiley & Sons Inc

Access to resources Recommend Favorite

Test Dose Pharmacokinetics in Pediatric Patients Receiving Once‐Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 332-339

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 18, Iss. 5, 2016-10 ,pp. : 690-698

John Wiley & Sons Inc

Access to resources Recommend Favorite

The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post‐first and post‐second hematopoietic stem cell transplant

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 4, 2015-06 ,pp. : 391-398

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplant recipients

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 234-241

John Wiley & Sons Inc

Access to resources Recommend Favorite